European cancer mortality predictions for the year 2012
- PMID: 22373539
- DOI: 10.1093/annonc/mds024
European cancer mortality predictions for the year 2012
Abstract
Background: Estimating current cancer mortality figures is important for defining priorities for prevention and treatment.
Materials and methods: Using logarithmic Poisson count data joinpoint models on mortality and population data from the World Health Organization database, we estimated numbers of deaths and age-standardized rates in 2012 from all cancers and selected cancer sites for the whole European Union (EU) and its six more populated countries.
Results: Cancer deaths in the EU in 2012 are estimated to be 1,283,101 (717,398 men and 565,703 women) corresponding to standardized overall cancer death rates of 139/100,000 men and 85/100,000 women. The fall from 2007 was 10% in men and 7% in women. In men, declines are predicted for stomach (-20%), leukemias (-11%), lung and prostate (-10%) and colorectal (-7%) cancers, and for stomach (-23%), leukemias (-12%), uterus and colorectum (-11%) and breast (-9%) in women. Almost stable rates are expected for pancreatic cancer (+2-3%) and increases for female lung cancer (+7%). Younger women show the greatest falls in breast cancer mortality rates in the EU (-17%), and declines are expected in all individual countries, except Poland.
Conclusion: Apart for lung cancer in women and pancreatic cancer, continuing falls are expected in mortality from major cancers in the EU.
Similar articles
-
European cancer mortality predictions for the year 2013.Ann Oncol. 2013 Mar;24(3):792-800. doi: 10.1093/annonc/mdt010. Epub 2013 Feb 12. Ann Oncol. 2013. PMID: 23402763
-
European cancer mortality predictions for the year 2014.Ann Oncol. 2014 Aug;25(8):1650-6. doi: 10.1093/annonc/mdu138. Epub 2014 Apr 23. Ann Oncol. 2014. PMID: 24759568
-
European cancer mortality predictions for the year 2011.Ann Oncol. 2011 Apr;22(4):947-956. doi: 10.1093/annonc/mdq774. Epub 2011 Feb 8. Ann Oncol. 2011. PMID: 21303801
-
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Eur J Cancer. 2018. PMID: 30100160 Review.
-
Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996.Lung Cancer. 1997 May;17(1):1-60. doi: 10.1016/s0169-5002(97)00648-x. Lung Cancer. 1997. PMID: 9194026 Review.
Cited by
-
New developments in the second-line treatment of metastatic colorectal cancer: potential place in therapy.Drugs. 2013 Jun;73(9):883-91. doi: 10.1007/s40265-013-0076-5. Drugs. 2013. PMID: 23743737 Review.
-
Years of life lost due to malignant neoplasms characterized by the highest mortality rate.Arch Med Sci. 2014 Oct 27;10(5):999-1006. doi: 10.5114/aoms.2013.36237. Epub 2014 Oct 23. Arch Med Sci. 2014. PMID: 25395953 Free PMC article.
-
The burden of premature mortality in Poland analysed with the use of standard expected years of life lost.BMC Public Health. 2015 Feb 7;15:101. doi: 10.1186/s12889-015-1487-x. BMC Public Health. 2015. PMID: 25884915 Free PMC article.
-
How to select the optimal treatment for first line metastatic colorectal cancer.World J Gastroenterol. 2014 Jan 28;20(4):899-907. doi: 10.3748/wjg.v20.i4.899. World J Gastroenterol. 2014. PMID: 24574764 Free PMC article. Review.
-
Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden.Br J Cancer. 2013 Nov 26;109(11):2917-23. doi: 10.1038/bjc.2013.689. Epub 2013 Oct 31. Br J Cancer. 2013. PMID: 24178755 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources